Lionakis, Michail S.

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Bastard, P., Rosen, L. B., Zhang, Q., Michailidis, E., Hoffmann, H.-H., Zhang, Y., Dorgham, K., Philippot, Q., Rosain, J., Béziat, V., et al. (2020) · Science

interferon and immune responsesSARS-CoV-2 and COVID-19 Research

Cited by 2,662

Invasive candidiasis

Pappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., & Kullberg, B. J. (2018) · Nature Reviews Disease Primers

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 1,636

Immune responses to human fungal pathogens and therapeutic prospects

Lionakis, M. S., Drummond, R. A., & Hohl, T. M. (2023) · Nature Reviews Immunology

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 379

Organ-Specific Innate Immune Responses in a Mouse Model of Invasive Candidiasis

Lionakis, M. S., Lim, J. K., Lee, C.-C. R., & Murphy, P. M. (2011) · Journal of Innate Immunity

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 302

The fungal peptide toxin Candidalysin activates the NLRP3 inflammasome and causes cytolysis in mononuclear phagocytes

Kasper, L., König, A., Koenig, P.-A., Gresnigt, M. S., Westman, J., Drummond, R. A., Lionakis, M. S., Groß, O., Ruland, J., Naglik, J. R., et al. (2018) · Nature Communications

Inflammasome and immune disordersAntifungal resistance and susceptibility

Cited by 297

Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways

Chamilos, G., Lionakis, M. S., & Kontoyiannis, D. P. (2018) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityNeutropenia and Cancer Infections

Cited by 267

On-going Mechanical Damage from Mastication Drives Homeostatic Th17 Cell Responses at the Oral Barrier

Dutzan, N., Abusleme, L., Bridgeman, H., Greenwell-Wild, T., Zangerle-Murray, T., Fife, M. E., Bouladoux, N., Linley, H., Brenchley, L., Wemyss, K., et al. (2017) · Immunity

Psoriasis: Treatment and PathogenesisT-cell and B-cell Immunology

Cited by 252

Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19

Sacco, K., Castagnoli, R., Vakkilainen, S., Liu, C., Delmonte, O. M., Oguz, C., Kaplan, I. M., Alehashemi, S., Burbelo, P. D., Bhuyan, F., et al. (2022) · Nature Medicine

Kawasaki Disease and Coronary ComplicationsCOVID-19 Clinical Research Studies

Cited by 247

CX3CR1-dependent renal macrophage survival promotes Candida control and host survival

Lionakis, M. S., Swamydas, M., Fischer, B. G., Plantinga, T. S., Johnson, M. D., Jaeger, M., Green, N. M., Masedunskas, A., Weigert, R., Mikelis, C., et al. (2013) · Journal of Clinical Investigation

Antifungal resistance and susceptibilityChemokine receptors and signaling

Cited by 230

Host Control of Fungal Infections: Lessons from Basic Studies and Human Cohorts

Lionakis, M. S., & Levitz, S. M. (2018) · Annual Review of Immunology

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 209

Aberrant type 1 immunity drives susceptibility to mucosal fungal infections.

Break, T. J., Oikonomou, V., Dutzan, N., Desai, J. V., Swidergall, M., Freiwald, T., Chauss, D., Harrison, O. J., Alejo, J., Williams, D. W., et al. (2021) · Science

Immunodeficiency and Autoimmune DisordersAntifungal resistance and susceptibility

Cited by 175

Extrapulmonary Aspergillus infection in patients with CARD9 deficiency

Rieber, N., Gazendam, R. P., Freeman, A. F., Hsu, A. P., Collar, A. L., Sugui, J. A., Drummond, R. A., Rongkavilit, C., Hoffman, K., Henderson, C., et al. (2016) · JCI Insight

Immunodeficiency and Autoimmune DisordersAntifungal resistance and susceptibility

Cited by 171

EphA2 is an epithelial cell pattern recognition receptor for fungal β-glucans

Swidergall, M., Solis, N. V., Lionakis, M. S., & Filler, S. G. (2017) · Nature Microbiology

Antifungal resistance and susceptibilityImmune Response and Inflammation

Cited by 167

Immunity against fungi

Lionakis, M. S., Iliev, I. D., & Hohl, T. M. (2017) · JCI Insight

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 153

Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions

Lionakis, M. S., Lewis, R. E., & Kontoyiannis, D. P. (2018) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 145

Murine model of colonization with fungal pathogen Candida auris to explore skin tropism, host risk factors and therapeutic strategies

Huang, X., Hurabielle, C., Drummond, R. A., Bouladoux, N., Desai, J. V., Sim, C. K., Belkaid, Y., Lionakis, M. S., & Segre, J. A. (2021) · Cell Host & Microbe

Antifungal resistance and susceptibilityInfection Control in Healthcare

Cited by 144

Long-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria

Drummond, R. A., Desai, J. V., Ricotta, E. E., Swamydas, M., Deming, C., Conlan, S., Quinones, M., Matei-Rascu, V., Sheriff, L., Lecky, D., et al. (2022) · Cell Host & Microbe

Antifungal resistance and susceptibilityGut microbiota and health

Cited by 141

Therapeutic responses to Roseomonas mucosa in atopic dermatitis may involve lipid-mediated TNF-related epithelial repair

Myles, I. A., Castillo, C. R., Barbian, K. D., Kanakabandi, K., Virtaneva, K., Fitzmeyer, E., Paneru, M., Otaizo-Carrasquero, F., Myers, T. G., Markowitz, T. E., et al. (2020) · Science Translational Medicine

Dermatology and Skin DiseasesProbiotics and Fermented Foods

Cited by 139

The role of neutrophils in host defense against invasive fungal infections

Desai, J. V., & Lionakis, M. S. (2018) · Current Clinical Microbiology Reports

Antifungal resistance and susceptibilityNeutrophil, Myeloperoxidase and Oxidative Mechanisms

Cited by 131

Candida auris Infections

Lionakis, M. S., & Chowdhary, A. (2024) · New England Journal of Medicine

Antifungal resistance and susceptibilityInfection Control in Healthcare

Cited by 130

Epidemiology of hospitalizations associated with invasive candidiasis, United States, 2002-20121

Strollo, S., Lionakis, M. S., Adjemian, J., Steiner, C. A., & Prevots, D. R. (2016) · Emerging Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 129

Oral epithelial IL-22/STAT3 signaling licenses IL-17-mediated immunity to oral mucosal candidiasis

Aggor, F. E. Y., Break, T. J., Trevejo-Nuñez, G., Whibley, N., Coleman, B. M., Bailey, R. D., Kaplan, D. H., Naglik, J. R., Shan, W., Shetty, A. C., et al. (2020) · Science Immunology

Cytokine Signaling Pathways and InteractionsPsoriasis: Treatment and Pathogenesis

Cited by 119

Chemokine Receptor Ccr1 Drives Neutrophil-Mediated Kidney Immunopathology and Mortality in Invasive Candidiasis

Lionakis, M. S., Fischer, B. G., Lim, J. K., Swamydas, M., Wan, W., Richard Lee, C.-C., Cohen, J. I., Scheinberg, P., Gao, J.-L., & Murphy, P. M. (2012) · PLoS Pathogens

Antifungal resistance and susceptibilityChemokine receptors and signaling

Cited by 118

Invasive candidiasis species distribution and trends, United States, 2009-2017

Ricotta, E. E., Lai, Y. L., Babiker, A., Strich, J. R., Kadri, S. S., Lionakis, M. S., Prevots, D. R., & Adjemian, J. (2021) · The Journal of Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 114